PMID: 7192855Nov 1, 1980Paper

The effects of extracellular potassium, ouabain, and prostaglandins on intracellular potassium activity in sheep cardica Purkinje fibers

Pflügers Archiv : European journal of physiology
M WiederholtK D Platsch


(1) Intracellular K activity (aKi) of sheep heart Purkinje fibers was measured using K-selective microelectrodes (liquid ion exchanger). aKi in the resting state with an extracellular K of 4 mmol . l-1 EK was 112.9 +/- 6.1 mmol . l-1 (n = 47) for a membrane potential (VM) of -73.3 +/- 0.9 mV. VM deviated from the calculated potassium equilibrium potential (EK = -93mV). (2) When extracellular K was decreased to 2 mmol . l-1 or increased to 6 and 10 mmol . l-1 EK changed from -114 to -84 and -73 mV, with little change in aKi. (3) aKi and VM significantly decreased after administration of 10(-6) mol . l-1 ouabain. (4) Prostaglandins (PGI2 10-100 micrograms . l-1 and PGE2 0.01-1 microgram . l-1) decreased aKi without greatly changing VM. The differences between VM and EK became smaller. These effects indicate an increase in K permeability and may explain the antiarrhythmic action of prostaglandins.


Jan 1, 1979·The American Journal of Cardiology·L H OpieW F Lubbe
Sep 1, 1979·The American Journal of Physiology·C O Lee, H A Fozzard
Oct 1, 1979·Experimental Eye Research·L L HansenM Wiederholt
Mar 11, 1977·Pflügers Archiv : European journal of physiology·N FowlerG Whittembury
Jan 1, 1974·Reviews of Physiology, Biochemistry and Pharmacology·M P Blaustein
Jun 1, 1973·Prostaglandins·W FörsterP Mentz
May 1, 1972·European Journal of Pharmacology·W G ZijlstraA J Vergroesen


Dec 1, 1989·Pflügers Archiv : European journal of physiology·E KrohnH J Bretschneider
Mar 1, 1983·Prostaglandins, Leukotrienes, and Medicine·H J Mest, J Rausch
Sep 1, 1996·Japanese Circulation Journal·Y KobayashiT Katagiri

Related Concepts

Electric Stimulation Technique
Potentials, Event-Related
Cardiac Conduction System
Resting Potentials
Structure of Purkinje Fibers
Dall Sheep

Related Feeds


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.